Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
JW Therapeutics Announces its Cell Immunotherapy Drugs Have Successfully Benefited 406 Patients 2023-03-30 08:00
Zimmer Biomet's ROSA HIP with ONE Planner Hip Awarded Orthopaedic Product Innovation of the Year by Healthcare Asia Medtech Awards 2023 2023-03-30 08:00
Athos Therapeutics Receives Regulatory Approval to Commence Phase I Clinical Trial of ATH-063 2023-03-30 03:32
Broncus Medical (02216.HK) Announces Annual Results for 2022 2023-03-30 01:05
PM Lee receives a first-hand update by Biosyngen on its progress in cell therapy 2023-03-29 22:53
LifeTech Reports Steady Growth of 32.5percent in Net Profit Attributable to Owners of the Company in 2022 2023-03-29 22:21
BGI Genomics Partners with Zentya to Launch Fecal DNA Test for Colorectal Cancer in Slovakia 2023-03-29 16:00
Transcenta's Osemitamab (TST001) Targeting Claudin18.2 Granted Orphan Drug Designation for Treatment of Pancreatic Cancer 2023-03-29 14:00
Antengene Announces First Patient Dosed with Claudin 18.2 Antibody-Drug Conjugate ATG-022 for the Treatment of Patients with Advanced or Metastatic Solid Tumors in Australia 2023-03-29 08:30
Innovent Announces 2022 Annual Results and Business Updates 2023-03-29 08:00
Verbal Beginnings partners with The Clinician to launch a Patient Reported Outcomes Program for Children with Autism Spectrum Disorder 2023-03-29 02:32
Antengene Announces Results for Full Year 2022 with Updates Highlighting a Sales Revenue Reaching 5.6 Times Year-Over-Year and Accelerated Global Innovation 2023-03-28 21:40
BIMINI HEALTH TECH ACQUIRES EXCLUSIVE LICENSE TO ACELLULAR DERMAL MATRIX PRODUCT PORTFOLIO 2023-03-28 21:20
New Study Reveals Clinical Instability Predicts Psychiatric Hospitalization 2023-03-28 21:00
Pulnovo Medical Announces 3-Year Follow-up Results from PADN-5 at THT 2023, The Medical Device Maker Breaks New Ground in Heart Failure Treatment 2023-03-28 20:30
WuXi Biologics Congratulates Amicus Therapeutics on European Commission Approval for Pombiliti™ in Patients with Late-Onset Pompe Disease 2023-03-28 20:11
Sirnaomics Announces 2022 Annual Results 2023-03-28 19:26
Seegene declares to share Syndromic PCR technologies to prevent future pandemics 2023-03-28 19:00
Grey Wolf Therapeutics Announces Dosing of First Patient in Phase 1/2 Clinical Study of GRWD5769 in Patients with Advanced Solid Tumours 2023-03-28 19:00
BD and A*STAR collaborate to Advance Ultra-High Dimensional Analysis in Flow Cytometry for Immunology Research 2023-03-28 14:12
1 127 128 129 130 131 538